Clinical trial

"Matrix Metalloproteinases 7 and 9 in Rheumatoid Arthritis Patients With Interstitial Lung Disease"

NCT07173582

Study summary

ClinicalTrials.gov

"Matrix Metalloproteinases 7 and 9 in Rheumatoid Arthritis Patients With Interstitial Lung Disease"

Design: OBSERVATIONAL · Status: NOT YET RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention Serum samples will be collected at the time of registry enrollment, MMP 7 and 9 concentrations will be measured using enzyme-linked immunosorbent assays. Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2025-10-01

PhaseN/A

Conditions

Rheumatoid Arthritis (RA)unresolved

Interventions

Serum samples will be collected at the time of registry enrollment, MMP 7 and 9 concentrations will be measured using enzyme-linked immunosorbent assays.DIAGNOSTIC_TEST

Sponsors & collaborators

Assiut Universitylead sponsor

Mapped research locations

AsyutEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07173582 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.